News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,178 Results
Type
Article (13665)
Company Profile (105)
Press Release (249408)
Section
Business (88095)
Career Advice (465)
Deals (15372)
Drug Delivery (64)
Drug Development (36565)
Employer Resources (49)
FDA (6275)
Job Trends (6200)
News (150249)
Policy (14036)
Tag
Academia (436)
Alliances (23190)
Alzheimer's disease (371)
Approvals (6285)
Artificial intelligence (75)
Bankruptcy (145)
Best Places to Work (4368)
Breast cancer (64)
Cancer (451)
Cardiovascular disease (47)
Career advice (407)
Cell therapy (62)
Clinical research (30638)
Collaboration (239)
Compensation (97)
COVID-19 (758)
C-suite (77)
Data (452)
Diabetes (65)
Diagnostics (1253)
Drug discovery (45)
Drug pricing (59)
Earnings (31709)
Events (37046)
Executive appointments (271)
FDA (6544)
Funding (156)
Gene therapy (72)
GLP-1 (314)
Government (1282)
Healthcare (3571)
Infectious disease (780)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5874)
Job creations (2050)
Job search strategy (373)
Layoffs (171)
Legal (3424)
Lung cancer (64)
Manufacturing (115)
Medical device (1274)
Medtech (1276)
Mergers & acquisitions (9601)
Metabolic disorders (200)
Neuroscience (498)
NextGen: Class of 2025 (1589)
Non-profit (591)
Northern California (555)
Obesity (119)
Opinion (113)
Patents (71)
People (28676)
Pharmaceutical (65)
Phase I (7980)
Phase II (12954)
Phase III (11634)
Pipeline (233)
Policy (47)
Postmarket research (1401)
Preclinical (3182)
Radiopharmaceuticals (117)
Rare diseases (119)
Real estate (2631)
Regulatory (9941)
Research institute (564)
Resumes & cover letters (55)
Southern California (540)
Startups (1630)
United States (5393)
Vaccines (123)
Weight loss (86)
Date
Today (52)
Last 7 days (190)
Last 30 days (762)
Last 365 days (12393)
2025 (731)
2024 (12523)
2023 (14270)
2022 (19578)
2021 (20090)
2020 (19062)
2019 (14917)
2018 (11741)
2017 (13900)
2016 (13137)
2015 (15486)
2014 (12429)
2013 (10598)
2012 (11407)
2011 (11926)
2010 (10890)
Location
Africa (313)
Arizona (46)
Asia (19957)
Australia (2578)
California (1300)
Canada (723)
China (170)
Colorado (52)
Connecticut (54)
Europe (39068)
Florida (217)
Illinois (146)
Indiana (105)
Japan (59)
Kansas (53)
Maryland (189)
Massachusetts (1115)
Minnesota (71)
New Jersey (538)
New York (360)
North Carolina (319)
Northern California (555)
Pennsylvania (338)
South America (500)
Southern California (540)
Texas (169)
Virginia (50)
Washington State (86)
263,178 Results for "sovereign pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Alora Pharmaceuticals Celebrates Acquisition of Monarch Manufacturing Facility
Alora Pharmaceuticals, LLC, is pleased to announce that its wholly owned subsidiary, Sovereign Pharmaceuticals, LLC, has acquired, through bankruptcy proceedings, substantially all of Monarch PCM, LLC’s manufacturing capabilities located in Fort Worth, TX.
January 10, 2023
·
2 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
January 14, 2025
·
6 min read
Press Releases
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
January 22, 2025
·
2 min read
Press Releases
Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee
December 18, 2024
·
3 min read
Press Releases
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
January 23, 2025
·
5 min read
Press Releases
InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds
January 22, 2025
·
5 min read
Press Releases
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
November 27, 2024
·
1 min read
Deals
Juvisé Pharmaceuticals Acquires Multiple Sclerosis Drug PONVORY® (ex-US/Canada) and Opens Its Capital to Bpifrance and Pemberton
The French pharmaceutical company, Juvisé Pharmaceuticals, announces the acquisition of global commercial rights (excluding the United States and Canada) to Ponvory® (ponesimod) from Actelion Pharmaceuticals Ltd., a Johnson & Johnson Company (Johnson & Johnson). Ponvory® is indicated for the treatment of adults with active forms of relapsing multiple sclerosis (RMS); it is protected by several patents, the latest of which expires in 2035.
March 26, 2024
·
4 min read
Press Releases
Corvus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
1 of 26,318
Next
